-- digiRX™ - Software to streamline and digitize the prescription handling process to eliminate handwritten errors, prescription loss, prescription forgery and improve the speed of patient information verification and prescription fulfillment. -- digiReAuth™ - Prescription reauthorization software used in conjunction with the company's call center, to process patient prescription reauthorizations digitally between the clinic and pharmacy, reducing physician workload and speeding up the process for the patient. -- digiPRN™ - Software connecting the Pharmacist to the Doctor's office for the process of receiving digital prescriptions. Pharmacists no longer need to worry about the security of the prescription since the doctor and pharmacist are on the same secure network.To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to ir@digimedical.com. About digiMedical Solutions, Inc.™ (www.digiMedical.com) digiMedical Solutions, Inc.™ is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite. Forward-Looking Statement Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission.
Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com